BlackRock Health Sciences Trust (NYSE:BME) Shares Up 0.5% – Time to Buy?

Shares of BlackRock Health Sciences Trust (NYSE:BME) shot up 0.5% during mid-day trading on Tuesday. The company traded as high as $47.93 and last traded at $47.9420. Approximately 53,788 shares were traded during trading, an increase of 21% from the average session volume of 44,553 shares. The stock had previously closed at $47.69.

BlackRock Health Sciences Trust Stock Performance

The company has a 50 day moving average price of $45.02 and a 200 day moving average price of $42.29.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be issued a dividend of $0.2621 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a $3.15 annualized dividend and a yield of 6.6%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Bank of America Corp DE acquired a new stake in BlackRock Health Sciences Trust during the second quarter worth approximately $11,827,000. HBK Sorce Advisory LLC acquired a new position in BlackRock Health Sciences Trust in the 2nd quarter valued at $572,000. Northwestern Mutual Wealth Management Co. purchased a new position in shares of BlackRock Health Sciences Trust during the 2nd quarter worth $69,000. LaSalle St. Investment Advisors LLC purchased a new position in shares of BlackRock Health Sciences Trust during the 2nd quarter worth $265,000. Finally, Root Financial Partners LLC purchased a new position in shares of BlackRock Health Sciences Trust during the 3rd quarter worth $26,000.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE:BME) is a closed-end investment company managed by BlackRock Advisors. The fund seeks to provide total return through a combination of current income and capital appreciation by investing primarily in the equity securities of companies involved in the health sciences sector. Its portfolio may include pharmaceutical, biotechnology, medical device, health care services, life sciences tools and diagnostics, and other related businesses. The fund can invest across a range of company sizes and may pursue opportunities in both U.S. and international markets, giving investors access to multiple segments of the global health care industry through a single investment vehicle.